Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

June 20, 2022

Study Completion Date

June 20, 2022

Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
DEVICE

gammaCore

The intervention consists of a transcutaneous non-invasive stimulation of the cervical branch of the vagus nerve (nVNS) using gammaCore, an FDA approved device for the treatment of migraine and cluster headache. This will be compared to the sham device, which is the same device which will not provide stimulation to the nerve. Stimulation frequency will be identical to the frequency used in previous nVNS studies for the treatment of migraine headache.

Trial Locations (1)

11030

Northshore University Hospital, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER